The Gavi advance market commitment for COVID-19 vaccines is a new financing instrument aimed at incentivizing vaccine manufacturers to produce sufficient and affordable quantities of COVID-19 vaccines. / read more /
The protocol on Northern Ireland (NI) once Brexit has been completed has received mixed opinions in industry, according to various press releases. / read more /
CPhI Worldwide have announced that the 2020 event will be organized in accordance with new global biosafety measures, Informa’s AllSecure health and safety standard, to ensure hygiene and safety of event attendees. / read more /
The agency is advising healthcare professionals to closely monitor patients with COVID-19 who are receiving chloroquine or hydroxychloroquine for potential side effects. / read more /
The European Commission has granted marketing authorization to the Janssen Pharmaceutical Companies of Johnson & Johnson for Darzalex (daratumumab) subcutaneous formulation to treat adults with multiple myeloma. / read more /
The medicine is the first outcome of the collaboration between Lilly and AbCellera to create antibody therapies for the prevention and treatment of COVID-19. / read more /
Suppliers to the bio/pharma industry are sharing news about the business operations during the global COVID-19 pandemic. To view current information about the company’s business operations, click the company name. / read more /
Single-use processing requires instruments providing the accuracy of traditional technologies but configured in form factors designed specifically for this service. / read more /
A contamination control strategy can prevent contamination in sterile product manufacturing. The right system, equipment, and personnel training are also essential to mitigate risk. / read more /
A variety of assays should be used to detect bacterial, fungal, and viral contaminants in the human source cells used for cell therapies. / read more /
Shimadzu’s Nexera Ultra High-Performance Liquid Chromatograph series, incorporates artificial intelligence as Analytical Intelligence, allows systems to detect and resolve issues automatically. / read more /
In Pharmaceutical Technology's ongoing Pharmacopoeia Compliance Series, experts explain the revision process for global and national pharmacopoeias, best practices for monitoring changes, and how to participate in revisions. Other features include FDA warning letters, building a quality culture, and essentials for DOE and QRM.
